These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 10381377

  • 21. Cloning and characterization of human SHIP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation.
    Ware MD, Rosten P, Damen JE, Liu L, Humphries RK, Krystal G.
    Blood; 1996 Oct 15; 88(8):2833-40. PubMed ID: 8874179
    [Abstract] [Full Text] [Related]

  • 22. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T, Ishiki M, Wada T, Hori H, Hirai H, Haruta T, Ishihara H, Kobayashi M.
    Endocrinology; 2001 Dec 15; 142(12):5226-35. PubMed ID: 11713219
    [Abstract] [Full Text] [Related]

  • 23. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.
    Pesesse X, Dewaste V, De Smedt F, Laffargue M, Giuriato S, Moreau C, Payrastre B, Erneux C.
    J Biol Chem; 2001 Jul 27; 276(30):28348-55. PubMed ID: 11349134
    [Abstract] [Full Text] [Related]

  • 24. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling.
    Ugi S, Imamura T, Ricketts W, Olefsky JM.
    Mol Cell Biol; 2002 Apr 27; 22(7):2375-87. PubMed ID: 11884620
    [Abstract] [Full Text] [Related]

  • 25. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.
    Gagnon A, Artemenko Y, Crapper T, Sorisky A.
    J Cell Physiol; 2003 Nov 27; 197(2):243-50. PubMed ID: 14502564
    [Abstract] [Full Text] [Related]

  • 26. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C.
    Biochem Biophys Res Commun; 2001 Apr 06; 282(3):839-43. PubMed ID: 11401540
    [Abstract] [Full Text] [Related]

  • 27. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.
    Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G.
    Proc Natl Acad Sci U S A; 1996 Feb 20; 93(4):1689-93. PubMed ID: 8643691
    [Abstract] [Full Text] [Related]

  • 28. Intracellular signalling pathways of okadaic acid leading to mitogenesis in Rat1 fibroblast overexpressing insulin receptors: okadaic acid regulates Shc phosphorylation by mechanisms independent of insulin.
    Sawa T, Sasaoka T, Hirai H, Ishihara H, Ishiki M, Wada T, Kobayashi M.
    Cell Signal; 1999 Nov 20; 11(11):797-803. PubMed ID: 10617282
    [Abstract] [Full Text] [Related]

  • 29. Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome.
    Buettner R, Ottinger I, Gerhardt-Salbert C, Wrede CE, Schölmerich J, Bollheimer LC.
    Am J Physiol Endocrinol Metab; 2007 Jun 20; 292(6):E1871-8. PubMed ID: 17327370
    [Abstract] [Full Text] [Related]

  • 30. The two SH2-domain-containing inositol 5-phosphatases SHIP1 and SHIP2 are coexpressed in human T lymphocytes.
    Bruyns C, Pesesse X, Moreau C, Blero D, Erneux C.
    Biol Chem; 1999 Jun 20; 380(7-8):969-74. PubMed ID: 10494849
    [Abstract] [Full Text] [Related]

  • 31. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A.
    J Biol Chem; 2005 Jun 10; 280(23):22523-9. PubMed ID: 15824124
    [Abstract] [Full Text] [Related]

  • 32. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
    Erneux C, Edimo WE, Deneubourg L, Pirson I.
    J Cell Biochem; 2011 Sep 10; 112(9):2203-9. PubMed ID: 21503961
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. SHC and SHIP phosphorylation and interaction in response to activation of the FLT3 receptor.
    Marchetto S, Fournier E, Beslu N, Aurran-Schleinitz T, Dubreuil P, Borg JP, Birnbaum D, Rosnet O.
    Leukemia; 1999 Sep 10; 13(9):1374-82. PubMed ID: 10482988
    [Abstract] [Full Text] [Related]

  • 38. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.
    Pesesse X, Deleu S, De Smedt F, Drayer L, Erneux C.
    Biochem Biophys Res Commun; 1997 Oct 29; 239(3):697-700. PubMed ID: 9367831
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T, Ishiki M, Sawa T, Ishihara H, Takata Y, Imamura T, Usui I, Olefsky JM, Kobayashi M.
    Endocrinology; 1996 Oct 29; 137(10):4427-34. PubMed ID: 8828504
    [Abstract] [Full Text] [Related]

  • 40. The SH2 domain containing inositol 5-phosphatase SHIP2 associates to the immunoreceptor tyrosine-based inhibition motif of Fc gammaRIIB in B cells under negative signaling.
    Muraille E, Bruhns P, Pesesse X, Daëron M, Erneux C.
    Immunol Lett; 2000 Apr 03; 72(1):7-15. PubMed ID: 10789675
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.